Search Results for: NVCN
Here 24/7 Wall St. has included a calendar of a few of the biggest companies expecting clinical trial and FDA updates in February.
Published:
Last Updated:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Wednesday, including NovoCure, Synchrony, Twitter and Yum! Brands.
Published:
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in September.
Published:
Last Updated:
The 54th annual meeting of the American Society of Clinical Oncology (ASCO) has just concluded and there were some significant moves we saw as a result.
Published:
Last Updated:
In a recent report from Wedbush Securities, the boutique brokerage firm recaps the COVID-19 impact on its coverage universe. Here, 24/7 Wall St. has picked out some of Wedbush’s top picks within...
Published:
This report was sent to Briefing.com subscribers earlier today. Upgrades: > Alphabet A (GOOGL) upgraded to Outperform from Neutral at Exane BNP Paribas; tgt $123 > American Airlines (AAL)...
Published:
Tuesday’s additional top analyst upgrades and downgrades were on Affirm, Canadian Pacific Railway, Darden Restaurants, Generac, Goodyear Tire & Rubber, Invitation Homes, PagSeguro Digital, Roku,...
Published:
Thursday's top analyst upgrades and downgrades included Boston Scientific, CVS Health, FMC, Lennar, NovoCure, Penn National Gaming, Ruth's Hospitality, Stitch Fix and Veeco Instruments.
Published:
Here is a first look at Monday's analyst upgrades and downgrades.
Published:
Here are consensus analysts' estimates of EPS and revenue for companies reporting quarterly earnings Thursday morning.
Published:
The top analyst upgrades, downgrades and other research calls from Thursday include Adtran, Alcoa, Clorox, Kinder Morgan, Lam Research, MGIC, Sprint and Walmart.
Published:
Last Updated:
With the market effectively at all-time highs after the election, investors are looking for new ideas to generate income or gains ahead. Sometimes investors turn to Wall Street research to look for...
Published:
Last Updated:
This report was sent to Briefing.com subscribers earlier today. Research calls posted earlier this morning are available here.  Upgrades: > Aligos Therapeutics (ALGS) upgraded to Buy from...
Published:
Before U.S. markets open Thursday morning, 114 companies are scheduled to report quarterly earnings results. The following table is based on data from Briefing.com and includes a consensus forecast...
Published:
The top analyst upgrades, downgrades and initiations seen on Wednesday included Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra Energy, Peabody Energy, Teva Pharmaceutical and...
Published:
Last Updated: